Evaluation of vesicular-bullous rash

Fine JD, Bruckner-Tuderman L, Eady RA, et al. Inherited epidermolysis bullosa: updated recommendations on diagnosis and classification. J Am Acad Dermatol. 2014 Jun;70(6):1103-26.Full text  Abstract

Nousari HC, Anhalt GJ. Pemphigus and bullous pemphigoid. Lancet. 1999 Aug 21;354(9179):667-72. Abstract

Mihai S, Sitaru C. Immunopathology and molecular diagnosis of autoimmune bullous diseases. J Cell Mol Med. 2007 May-Jun;11(3):462-81.Full text  Abstract

Schmidt E, Zillikens D. Modern diagnosis of autoimmune blistering skin diseases. Autoimmun Rev. 2010 Dec;10(2):84-9. Abstract

Parker SR, MacKelfresh J. Autoimmune blistering diseases in the elderly. Clin Dermatol. 2011 Jan-Feb;29(1):69-79. Abstract

1. Berger TG, James WD, Elston DM. Andrew's diseases of the skin, clinical dermatology, 10th edition. WB Saunders; 2008.

2. Harper J, Oranje A, Prose N. Textbook of pediatric dermatology, Volume 1. Blackwell Science; 2000.

3. Joly P, Horvath B, Patsatsi Α, et al. Updated S2K guidelines on the management of pemphigus vulgaris and foliaceus initiated by the european academy of dermatology and venereology (EADV). J Eur Acad Dermatol Venereol. 2020 Sep;34(9):1900-13.Full text  Abstract

4. Jaworsky C, Murphy G. Special techniques in dermatology. Arch Dermatol. 1989 Jul;125(7):963-74. Abstract

5. Miller JM, Binnicker MJ, Campbell S, et al. A guide to utilization of the microbiology laboratory for diagnosis of infectious diseases: 2018 update by the Infectious Diseases Society of America and the American Society for Microbiology. Clin Infect Dis. 2018 Aug 31;67(6):e1-94.Full text  Abstract

6. Lowy G. Sexually transmitted diseases in children. Pediatr Dermatol. 1992 Dec;9(4):329-34. Abstract

7. Bolognia J, Jorizzo JL, Rapini RP. Dermatology, 2nd edition, volume 1. Philadelphia, PA: Mosby Saunders; 2008.

8. Robinson CR, Doane FW, Rhodes AJ. Report of an outbreak of febrile illness with pharyngeal lesions and exanthem: Toronto, summer 1957; isolation of group A Coxsackie virus. Can Med Assoc J. 1958 Oct 15;79(8):615-21.Full text  Abstract

9. Wozniacka A, Hawro T, Schwartz RA. Bullous scabies: a diagnostic challenge. Cutis. 2008 Nov;82(5):350-2. Abstract

10. Weinstock MA, Kempton SA. Case report: teledermatology and epiluminescence microscopy for the diagnosis of scabies. Cutis. 2000 Jul;66(1):61-2. Abstract

11. Uitto J, Richard G. Progress in epidermolysis bullosa: genetic classifications and clinical implications. Am J Med Genet C Semin Med Genet. 2004 Nov 15;131C(1):61-74. Abstract

12. Fine JD, Bruckner-Tuderman L, Eady RA, et al. Inherited epidermolysis bullosa: updated recommendations on diagnosis and classification. J Am Acad Dermatol. 2014 Jun;70(6):1103-26.Full text  Abstract

13. Elder DE, Elenitsas R, Johnson BL Jr, et al. Lever's histopathology of the skin. 10th edition. Philadelphia, PA: Lippincott Williams and Wilkins; 2009.

14. Ramdial PK, Naidoo DK. Drug-induced skin pathology. J Clin Pathol. 2009 Jun;62(6):493-504.Full text  Abstract

15. Hoeger PH, Harper JI. Neonatal erythroderma: differential diagnosis and management of the "red baby." Arch Dis Child. 1998 Aug;79(2):186-91.Full text  Abstract

16. Alto WA, Clarcq L. Cutaneous and systemic manifestations of mastocytosis. Am Fam Physician. 1999 Jun;59(11):3047-54;3059-60.Full text  Abstract

17. Wang L, Varghese S, Bassir F, et al. Stevens-Johnson syndrome and toxic epidermal necrolysis: a systematic review of PubMed/MEDLINE case reports from 1980 to 2020. Front Med (Lausanne). 2022 Aug 24;9:949520.Full text  Abstract

18. Lane K, Lumbang W. Pruritic blisters on legs and feet. J Fam Pract. 2008 Mar;57(3):177-80. Abstract

19. Nousari HC, Anhalt GJ. Pemphigus and bullous pemphigoid. Lancet. 1999 Aug 21;354(9179):667-72. Abstract

20. Yeh SW, Ahmed B, Sami N, et al. Blistering disorders: diagnosis and treatment. Dermatol Ther. 2003;16(3):214-23. Abstract

21. Bickle K, Roark TR, Hsu S. Autoimmune bullous disease: a review. Am Fam Physician. 2002 May 1;65(9):1861-70.Full text  Abstract

22. Mihai S, Sitaru C. Immunopathology and molecular diagnosis of autoimmune bullous diseases. J Cell Mol Med. 2007 May-Jun;11(3):462-81.Full text  Abstract

23. Liu SD, Chen WT, Chi CC. Association between medication use and bullous pemphigoid: a systematic review and meta-analysis. JAMA Dermatol. 2020 Aug 1;156(8):891-900.Full text  Abstract

24. Schwartzman G, Simpson MM, Jones R, et al. Anti-PD1 immune checkpoint inhibitor-induced bullous pemphigoid in metastatic melanoma and non-small cell lung cancer. Cutis. 2020 Jun;105(6):E9-12. Abstract

25. Avram MA, Gobel V, Sepehr A. Case records of the Massachusetts General Hospital. Case 30-2007: a newborn girl with skin lesions. N Engl J Med. 2007 Sep 27;357(13):1327-35. Abstract

26. Gilden DH, Kleinschmidt-DeMasters BK, LaGuardia JJ, et al. Neurologic complications of the reactivation of varicella-zoster virus. N Engl J Med. 2000 Mar 2;342(9):635-45. Abstract

27. Howell ER, Phillips CM. Cutaneous manifestations of Staphylococcus aureus disease. Skinmed. 2007 Nov-Dec;6(6):274-9. Abstract

28. Fisler RE, Saeb M, Liang MG, et al. Childhood bullous pemphigoid: a clinicopathologic study and review of the literature. Am J Dermatopathol. 2003 Jun;25(3):183-9. Abstract

29. Kridin K, Bergman R. Association of bullous pemphigoid with dipeptidyl-peptidase 4 inhibitors in patients with diabetes: estimating the risk of the new agents and characterizing the patients. JAMA Dermatol. 2018 Oct 1;154(10):1152-8. Abstract

30. Lee SG, Lee HJ, Yoon MS, et al. Association of dipeptidyl peptidase 4 inhibitor use with risk of bullous pemphigoid in patients with diabetes. JAMA Dermatol. 2019 Feb 1;155(2):172-7. Abstract

31. Benzaquen M, Borradori L, Berbis P, et al. Dipeptidyl peptidase IV inhibitors, a risk factor for bullous pemphigoid: retrospective multicenter case-control study from France and Switzerland. J Am Acad Dermatol. 2018 Jun;78(6):1090-6. Abstract

32. Muller UR, Haeberli G. The problem of anaphylaxis and mastocytosis. Curr Allergy Asthma Rep. 2009 Jan;9(1):64-70. Abstract

33. Zimmermann S, Sekula P, Venhoff M, et al. Systemic immunomodulating therapies for Stevens-Johnson syndrome and toxic epidermal necrolysis: a systematic review and meta-analysis. JAMA Dermatol. 2017 Jun 1;153(6):514-22.Full text  Abstract

34. Schneider JA, Cohen PR. Stevens-Johnson syndrome and toxic epidermal necrolysis: a concise review with a comprehensive summary of therapeutic interventions emphasizing supportive measures. Adv Ther. 2017 Jun;34(6):1235-44.Full text  Abstract

35. Meuwissen ME, Mancini GM. Neurological findings in incontinentia pigmenti: a review. Eur J Med Genet. 2012 May;55(5):323-31. Abstract

36. Hendricks WM. Pellagra and pellagralike dermatoses: etiology, differential diagnosis, dermatopathology, and treatment. Semin Dermatol. 1991 Dec;10(4):282-92. Abstract

37. Darmstadt GL, Lane AT. Impetigo: an overview. Pediatr Dermatol. 1994 Dec;11(4):293-303. Abstract

38. Durdu M, Baba M, Seçkin D. The value of Tzanck smear test in diagnosis of erosive, vesicular, bullous, and pustular skin lesions. J Am Acad Dermatol. 2008 Dec;59(6):958-64. Abstract

39. Schmidt E, Zillikens D. Modern diagnosis of autoimmune blistering skin diseases. Autoimmun Rev. 2010 Dec;10(2):84-9. Abstract

40. Parker SR, MacKelfresh J. Autoimmune blistering diseases in the elderly. Clin Dermatol. 2011 Jan-Feb;29(1):69-79. Abstract

41. Diaz LA, Giudice GJ. End of the century overview of skin blisters. Arch Dermatol. 2000 Jan;136(1):106-12. Abstract

42. Reina J, Saurina J, Fernandez-Baca V, et al. Evaluation of a direct immunofluorescence cytospin assay for the detection of herpes simplex virus in clinical samples. Eur J Clin Microbiol Infect Dis. 1997 Nov;16(11):851-4. Abstract

43. Wald A, Huang ML, Carrell D, et al. Polymerase chain reaction for detection of herpes simplex virus (HSV) DNA on mucosal surfaces: comparison with HSV isolation in cell culture. J Infect Dis. 2003 Nov 1;188(9):1345-51.Full text  Abstract

44. Guerry SL, Bauer HM, Klausner JD, et al. Recommendations for the selective use of herpes simplex virus type 2 serological tests. Clin Infect Dis. 2005 Jan 1;40(1):38-45.Full text  Abstract

45. Dahl H, Marcoccia J, Linde A. Antigen detection: the method of choice in comparison with virus isolation and serology for laboratory diagnosis of herpes zoster in human immunodeficiency virus-infected patients. J Clin Microbiol. 1997 Feb;35(2):347-9.Full text  Abstract

46. Landy SJ, Donnai D. Incontinentia pigmenti (Bloch-Sulzberger syndrome). J Med Genet. 1993 Jan;30(1):53-9.Full text  Abstract

47. Vyas K, Morgaonkar M, Gupta S, et al. Primary systemic amyloidosis with unusual dermatological manifestations: a rare case report. Indian J Dermatol. 2016 Mar-Apr;61(2):216-8.Full text  Abstract

48. Gottlieb J, Ingen-Housz-Oro S, Alexandre M, et al. Idiopathic linear IgA bullous dermatosis: prognostic factors based on a case series of 72 adults. Br J Dermatol. 2017 Jul;177(1):212-22. Abstract